En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
17700.1 PFNM-NM
Titre du projet
Development of a versatile electronic correlator that enables processing of a GHz modulated signal for advanced dynamic light scattering applications and nanoparticle sizing
Titre du projet anglais
Development of a versatile electronic correlator that enables processing of a GHz modulated signal for advanced dynamic light scattering applications and nanoparticle sizing

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
Anzeigen
-
-
Anzeigen
Résumé des résultats (Abstract)
Anzeigen
-
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Allemand)
Development of a versatile electronic correlator that enables processing of a GHz modulated signal for advanced dynamic light scattering applications and nanoparticle sizing
Description succincte
(Anglais)
Development of a versatile electronic correlator that enables processing of a GHz modulated signal for advanced dynamic light scattering applications and nanoparticle sizing
Résumé des résultats (Abstract)
(Allemand)
A novel class of electronic correlator will be developed that will significantly enhance the DLS technology and thus allow characterization of an important range of nanoparticle samples which could not be measured well so far. This correlator will be integrated into one of the most advanced DLS instruments, the NanoLab 3D, where it will reduce production cost and remove a limitation that has blocked access to the important pharmaceutical and biotechnology markets.
Résumé des résultats (Abstract)
(Anglais)
A novel class of electronic correlator will be developed that will significantly enhance the DLS technology and thus allow characterization of an important range of nanoparticle samples which could not be measured well so far. This correlator will be integrated into one of the most advanced DLS instruments, the NanoLab 3D, where it will reduce production cost and remove a limitation that has blocked access to the important pharmaceutical and biotechnology markets.